Learning outcomes
By the end of this lesson you should be able to: state the normal age ranges of puberty and of the menopause; list the pubertal stages in girls and their hormonal basis; describe the features and the consequences of oestrogen deficiency at the menopause; distinguish the symptoms of the menopause from those that are not; state what an initial assessment in gynaecology comprises and how it is performed; and identify which symptoms require urgent gynaecological assessment.
Prerequisites
Lessons 1-2, and PHYS 101 module 1 (feedback loops). The menopause is the switching off of the same loops that puberty switched on.
The big idea
The menopause is a natural event rather than a disease, and the problem is that the fall in oestrogen has consequences: vasomotor symptoms in the short term, and accelerated bone loss and genitourinary and genital atrophy in the long term. Management is a judgement of symptoms against risks, because hormone replacement is effective for the symptoms and slightly increases the risk of venous thromboembolism, stroke and breast cancer in some groups and some durations.
Worked example: puberty
| Stage | Age range | Feature | Driver |
|---|---|---|---|
| Thelarche | 10 to 11 | Breast budding | Oestrogen from the activating ovaries |
| Pubarche | 10 to 12 | Sexual hair | Adrenal androgens |
| Growth spurt | 11 to 13 | Accelerated linear growth, which is the earliest pubertal change in boys | Growth hormone acting with the sex steroids |
| Menarche | 12 to 13 (range 10 to 16) | The first menstrual period | The maturation of the hypothalamic-pituitary-gonadal axis |
Precocious puberty is the appearance of secondary sexual characteristics before the age of 8 in girls and 9 in boys, and delayed puberty is their absence beyond the age of 13. In girls, menarche usually follows the onset of breast development by about two years, and the menstrual cycles in the first one or two years are commonly anovulatory, which explains both the irregular bleeding and the relative infertility of adolescence.
Menopause
| Feature | Timing | Explanation |
|---|---|---|
| Irregular cycles then amenorrhoea | Over several years before the final period | The follicle supply is falling, ovulation becomes rare, and cycles become anovulatory |
| Vasomotor symptoms | Perimenopause to several years after | Short-term vasomotor activation (flushing and sweating), which is why hormone replacement is effective |
| Genitourinary atrophy | Years after the menopause | The thinning of the vaginal and urinary epithelium causes dryness and recurrent urinary infections |
| Bone loss | Years after the menopause | Accelerated loss of bone because oestrogen normally inhibits osteoclast activity, increasing the risk of osteoporosis and fracture |
| Mood changes | Variable | A combination of sleep disruption from the flushes, and the direct effect of falling oestrogen |
Hormone replacement therapy consists of oestrogen (with a progestogen in any woman who still has a uterus, to protect the endometrium from hyperplasia) and it is the most effective treatment for the vasomotor symptoms and the genitourinary atrophy. The benefits and risks are weighed against the age of the patient, her symptom burden, and her risk factors for thromboembolism, stroke, breast cancer and cardiovascular disease, and the treatment is used at the lowest effective dose with regular review.
Watch outThe slide that most often catches a student is the uterus. A woman with an intact uterus who is given systemic oestrogen and not a progestogen risks endometrial hyperplasia and carcinoma, so combined therapy is mandatory in that group, and systemic oestrogen alone is reserved for the woman who has had a hysterectomy.
Assessment in gynaecology
| Aspect | What is asked or done |
|---|---|
| History | The presenting complaint, the menstrual history, the obstetric history, the contraception, the sexual history and the cervical screening, and the drug history, including hormonal medication |
| Examination | A general examination including anaemia and signs of endocrine disease; abdominal palpation for mass and tenderness; and a pelvic examination with a chaperone |
| Pelvic examination | External inspection; a speculum examination of the cervix (visualisation and sampling if needed); and a bimanual examination to feel the size, the position and the mobility of the uterus and the adnexa |
| Investigation | Pregnancy test, pelvic ultrasound, cervical sampling, swabs, and blood tests including haemoglobin, thyroid and hormone profile where indicated |
A chaperone is mandatory, and the offer of one must be made and documented; the examination must be explained and consent obtained; and the examination is performed with the patient's privacy and dignity protected. These are not decoration but a part of the clinical method: a pelvic examination performed without consent is an assault, and a chaperone who is not present is indefensible in any dispute.
Red flags
| Presentation | Urgency | Why |
|---|---|---|
| Post-coital or post-menopausal bleeding | Urgent, within two weeks under the cancer pathway | It is a symptom of cervical and endometrial cancer until proven otherwise |
| Persistent pelvic or abdominal bloating, difficulty eating or feeling full quickly | Urgent assessment for ovarian cancer | These are the symptoms with the highest association with ovarian cancer, and the diagnosis is late |
| A vulval or vaginal ulcer or lump, an unexplained discharge with bleeding | Urgent | It may be vulval or vaginal cancer |
Common mistakes
Watch outSaying the menopause is diagnosed by a single raised follicle-stimulating hormone level. It is not: the diagnosis is clinical after twelve months of amenorrhoea, and the follicle-stimulating hormone fluctuates and is not a reliable single value.
Watch outSaying every post-menopausal bleed is atrophic. It must be investigated with an ultrasound and endometrial sampling before it is attributed to atrophy.
Watch outSkipping the chaperone because the patient appears comfortable. The chaperone is for the record as much as for the patient, and the offer is documented even if declined.
Check your understanding
What are the features of the perimenopause and when does it begin?
Why must a woman with an intact uterus on systemic hormone replacement take a progestogen as well?
Which symptoms suggest that an ovarian cancer should be considered in a post-menopausal woman?
Multiple choice
At what average age does the natural menopause occur?
Which of these is a symptom of post-menopausal atrophy?
Why must systemic hormone replacement therapy include a progestogen in a woman who has a uterus?
Which presentation requires urgent referral for possible cervical or endometrial cancer?
Why is a chaperone offered and documented at every pelvic examination?
Summary and next
Puberty switches on the hypothalamic-pituitary-ovarian loop and the menopause switches it off. The menopause, at an average age of about 51 and defined retrospectively by twelve months of amenorrhoea, is a natural process whose consequences of vasomotor symptoms, genitourinary atrophy and bone loss make hormone replacement a judgement of symptoms against risk — and a woman with a uterus needs a progestogen with her systemic oestrogen. The assessment in gynaecology is a structured history and examination with a chaperone, and post-coital and post-menopausal bleeding and the symptoms of ovarian cancer require urgent assessment.